Incorporating historical control data in planning phase II clinical trials

1990 ◽  
Vol 9 (3) ◽  
pp. 215-228 ◽  
Author(s):  
Peter F. Thall ◽  
Richard Simon
2013 ◽  
Vol 13 (1) ◽  
pp. 41-54 ◽  
Author(s):  
Kert Viele ◽  
Scott Berry ◽  
Beat Neuenschwander ◽  
Billy Amzal ◽  
Fang Chen ◽  
...  

2015 ◽  
Vol 36 (1) ◽  
pp. 25-50 ◽  
Author(s):  
Kentaro Takeda ◽  
Mari Oba ◽  
Tomoyuki Kakizume ◽  
Kentaro Sakamaki ◽  
Masataka Taguri ◽  
...  

Trials ◽  
2015 ◽  
Vol 16 (S2) ◽  
Author(s):  
Maxine Bennett ◽  
William Powley ◽  
Jeffrey Wetherington ◽  
Adrian Mander

2017 ◽  
Vol 16 (4) ◽  
pp. 296-308 ◽  
Author(s):  
Baoguang Han ◽  
Jia Zhan ◽  
Z. John Zhong ◽  
Dawei Liu ◽  
Stacy Lindborg

2020 ◽  
Vol 20 (19) ◽  
pp. 2019-2035
Author(s):  
Esmaeil Sheikh Ahmadi ◽  
Amir Tajbakhsh ◽  
Milad Iranshahy ◽  
Javad Asili ◽  
Nadine Kretschmer ◽  
...  

Naturally occurring naphthoquinones (NQs) comprising highly reactive small molecules are the subject of increasing attention due to their promising biological activities such as antioxidant, antimicrobial, apoptosis-inducing activities, and especially anticancer activity. Lapachol, lapachone, and napabucasin belong to the NQs and are in phase II clinical trials for the treatment of many cancers. This review aims to provide a comprehensive and updated overview on the biological activities of several new NQs isolated from different species of plants reported from January 2013 to January 2020, their potential therapeutic applications and their clinical significance.


2014 ◽  
Vol 54 (3) ◽  
pp. 150-161 ◽  
Author(s):  
Makoto Ema ◽  
Katsumi Endoh ◽  
Ryou Fukushima ◽  
Sakiko Fujii ◽  
Hiroaki Hara ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document